Cai, L., Li, Y., Tan, J., Xu, L., & Li, Y. (2023). Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy. Journal of Hematology & Oncology, 16(1), 1. https://doi.org/10.1186/s13045-023-01499-1
Chicago Style (17th ed.) CitationCai, Letong, Yuchen Li, Jiaxiong Tan, Ling Xu, and Yangqiu Li. "Targeting LAG-3, TIM-3, and TIGIT for Cancer Immunotherapy." Journal of Hematology & Oncology 16, no. 1 (2023): 1. https://doi.org/10.1186/s13045-023-01499-1.
MLA (9th ed.) CitationCai, Letong, et al. "Targeting LAG-3, TIM-3, and TIGIT for Cancer Immunotherapy." Journal of Hematology & Oncology, vol. 16, no. 1, 2023, p. 1, https://doi.org/10.1186/s13045-023-01499-1.
Warning: These citations may not always be 100% accurate.